We previously found that elevated PM2.5 levels were linked to increased risk of TP53 somatic mutations (Erhunmwunsee et al. 2021), which, like KRAS somatic mutations, are associated with worse NSCLC mortality. The gene discussed is TP53; the disease is non-small cell lung carcinoma.